A Study to Observe Demography and the Outcome of Prostate Cancer Patients Treated With 6-month Triptorelin Formulation in Italy

CompletedOBSERVATIONAL
Enrollment

167

Participants

Timeline

Start Date

April 24, 2023

Primary Completion Date

September 30, 2024

Study Completion Date

September 30, 2024

Conditions
Prostate Cancer
Trial Locations (13)

20089

IRCCS Istituto Clinico Humanitas, Rozzano

22042

Ospedale Sant'Anna, San Fermo della Battaglia

24125

Humanitas Gavazzeni, Bergamo

33100

Azienda Sanitaria Universitaria Friuli Centrale, Udine

37024

IRCCS Ospedale Sacro Cuore-Don Calabria, Cancer Care Center Negrar, Negrar

50134

Azienda Ospedaliera Universitaria Careggi, Florence

80078

Ospedale Santa Maria delle Grazia, Pozzuoli

80131

Azienda Ospedaliera Universitaria Federico II, Napoli

90123

Ospedale Buccheri La Ferla Fatebenefratelli di Palermo, Palermo

95123

"AOU Policlinico Gaspare Rodolico", Catania

04100

Ospedale ICOT, Latina

06132

Ospedale Santa Maria della Misericordia, Perugia

00189

Azienda Ospedaliera Universitaria Sant'Andrea, Roma

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Ipsen

INDUSTRY